Dear NONMEM users, At AbbVie, we have great opportunities for Pharmacometricians that are interested in supporting clinical decision making and agency interactions in early to late-stage clinical drug development by hands-on modelling in NONMEM and R.
Please check out the following opportunities at different levels of experience near Chicago, Illinois and in Germany. Pharmacometrician (near Chicago, Illinois): https://careers.abbvie.com/en/job/pharmacometrician-hybrid-il-based-in-north-chicago-il-jid-6321 Associate Director Pharmacometrics (near Chicago, Illinois): https://careers.abbvie.com/en/job/associate-director-pharmacometrics-immunology-and-virology-hybrid-in-north-chicago-il-jid-6916 https://careers.abbvie.com/en/job/associate-director-pharmacometrics-on-site-il-based-in-north-chicago-il-jid-3054 Senior Pharmacometrician (Ludwigshafen, Germany): https://careers.abbvie.com/en/job/senior-pharmacometrician-all-genders-12-months-temporary-full-or-part-time-in-ludwigshafen-rp-jid-8114 Best regards, Insa Insa Winzenborg, PhD Research Fellow & Director Pharmacometrics Clinical Pharmacology AbbVie Deutschland GmbH & Co KG ________________________________ Sitz der Gesellschaft: Wiesbaden - Registergericht: AG Wiesbaden HRA 9790 Pers?nlich haftende Gesellschafterin: AbbVie Komplement?r GmbH Sitz der pers?nlich haftenden Gesellschafterin: Wiesbaden - Registergericht: AG Wiesbaden HRB 26371 Gesch?ftsf?hrung: Lennaert Rijken, Emilie Demare Diet, Dr. Martin Gastens, Dr. Thomas Merdan, Scott Reents Vorsitzende des Aufsichtsrats: Dr. Azita Saleki-Gerhardt This communication may contain information that is proprietary, confidential, or exempt from disclosure. If you are not the intended recipient, please note that any other dissemination, distribution, use or copying of this communication is strictly prohibited. Anyone who receives this message in error should notify the sender immediately by telephone or by return e-mail and delete it from his or her computer. Diese Kommunikation kann Informationen enthalten, die geheim, vertraulich oder hinsichtlich der Offenlegung beschr?nkt sind. Wenn Sie nicht der beabsichtigte Empf?nger sind, nehmen Sie bitte zur Kenntnis, dass jede Weitergabe, Verteilung, Verwendung oder Vervielf?ltigung dieser. Kommunikation strikt untersagt ist. Jeder, der diese Nachricht fehlerhaft erh?lt, sollte den Sender unverz?glich telefonisch oder durch R?cksendung der E-Mail benachrichtigen und diese von seinem oder ihrem Computer l?schen.
